FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1

Shikha Khatri1, Hasmik Yepiskoposyan, Catherine A Gallo

  • 1Department of Cancer and Cell Biology, University of Cincinnati, Cincinnati, Ohio 45267, USA.

Insights

The transcription factor FoxO3a regulates cancer cell glycolysis by controlling Tsc1 expression. Loss of FoxO3a increases glycolysis and apoptosis resistance, highlighting a new therapeutic target in cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Akt signaling promotes cancer cell survival and proliferation by increasing glycolysis and resistance to apoptosis.
  • FoxO transcription factors are key regulators of apoptosis downstream of Akt, but their role in glycolysis is unclear.

Purpose of the Study:

  • To investigate the role of FoxO transcription factors, specifically FoxO3a, in regulating Akt-induced glycolysis in cancer cells.
  • To elucidate the molecular mechanisms by which FoxO3a influences glycolysis and apoptosis resistance.

Main Methods:

  • FoxO3a knockdown in cancer cells.
  • Measurement of glycolysis rates and apoptosis.
  • Analysis of signaling pathways including mTORC1, S6K1, and TSC1.
  • Luciferase reporter assays to assess transcriptional activity on the TSC1 promoter.

Main Results:

  • FoxO3a knockdown led to increased glycolysis and apoptosis resistance.
  • Elevated glycolysis in FoxO3a-deficient cells was linked to mTORC1 activation and decreased TSC1 expression.
  • FoxO3a was found to directly bind and transactivate the TSC1 promoter, indicating transcriptional regulation.
  • Rapamycin treatment, an mTORC1 inhibitor, reduced glycolysis in FoxO3a-deficient cells.

Conclusions:

  • FoxO3a plays a critical role in regulating cancer cell glycolysis downstream of Akt signaling.
  • FoxO3a controls glycolysis by transcriptionally upregulating TSC1, which in turn inhibits mTORC1.
  • Targeting FoxO3a or its downstream effectors may offer novel therapeutic strategies for cancers driven by Akt signaling.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...